Abstract
The G-protein coupled receptor system is involved in a range of cell types and actions and as such has a universal potential in identifying cell functions.
The most widely explored system is that of the somatostatin receptors which has been exploited for both imaging and therapy. However, even with this fairly simple system, variation is seen in the behaviour of cells between patients and within different cell population within the patient.
Newer work will exploit different ligands in a wider range of both tumour types and non-oncological processes such as inflammation.
Keywords: Bombesin, Chemokines, G Protein Coupled Receptors, Inflammation, Imaging, Personalized medicine, Somatostatin Receptors, Targeted Therapy.
Current Pharmaceutical Design
Title:Radiolabeled Probes Targeting G-Protein-Coupled Receptors for Personalized Medicine
Volume: 20 Issue: 14
Author(s): John Buscombe
Affiliation:
Keywords: Bombesin, Chemokines, G Protein Coupled Receptors, Inflammation, Imaging, Personalized medicine, Somatostatin Receptors, Targeted Therapy.
Abstract: The G-protein coupled receptor system is involved in a range of cell types and actions and as such has a universal potential in identifying cell functions.
The most widely explored system is that of the somatostatin receptors which has been exploited for both imaging and therapy. However, even with this fairly simple system, variation is seen in the behaviour of cells between patients and within different cell population within the patient.
Newer work will exploit different ligands in a wider range of both tumour types and non-oncological processes such as inflammation.
Export Options
About this article
Cite this article as:
Buscombe John, Radiolabeled Probes Targeting G-Protein-Coupled Receptors for Personalized Medicine, Current Pharmaceutical Design 2014; 20 (14) . https://dx.doi.org/10.2174/13816128113196660660
DOI https://dx.doi.org/10.2174/13816128113196660660 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Analysis of Adverse Events Related to 720 Cases of Neural Progenitor Cell Transplantation
CNS & Neurological Disorders - Drug Targets Stem Cells as Vectors to Deliver HSV/tk Gene Therapy for Malignant Gliomas
Current Stem Cell Research & Therapy Host Pharmacogenetics in the Treatment of HIV and Cancer
Current Drug Safety The Critical Role of Vascular Endothelial Growth Factor in Tumor Angiogenesis
Current Cancer Drug Targets Angiogenesis Inhibitors and Radiation in Multimodality Cancer Therapy: Preclinical and Clinical Studies
Current Angiogenesis (Discontinued) Fibroblast Growth Factor-2 Antagonist and Antiangiogenic Activity of Long-Pentraxin 3-Derived Synthetic Peptides
Current Pharmaceutical Design Molecular Mechanisms Regulating mRNA Stability: Physiological and Pathological Significance
Current Genomics Recent Advances on Small-Molecule Survivin Inhibitors
Current Medicinal Chemistry Epigenetics in Clinical Management of Children and Adolescents with Brain Tumors
Current Cancer Drug Targets Signal Transducer and Activator of Transcription 3 Signaling Pathway: A Potential Target in Sarcoma Treatment
Current Enzyme Inhibition Using Free and Open-Source Bioconductor Packages to Analyze Array Comparative Genomics Hybridization (aCGH) Data
Current Genomics Doxycycline as Potential Anti-cancer Agent
Anti-Cancer Agents in Medicinal Chemistry Cation-Responsive MRI Contrast Agents Based on Gadolinium(III)
Current Inorganic Chemistry (Discontinued) Will Arsenic Trioxide Benefit Treatment of Solid Tumor by Nano- Encapsulation?
Mini-Reviews in Medicinal Chemistry Antiangiogenesis and Radiotherapy: What Is the Role of Combined Modality Treatment?
Current Medicinal Chemistry - Anti-Cancer Agents Vascular Endothelial Growth Factor and Its Receptor as Drug Targets in Hematological Malignancies
Current Drug Targets Down Regulated Expression of Claudin-1 and Claudin-5 and Up Regulation of β-Catenin: Association with Human Glioma Progression
CNS & Neurological Disorders - Drug Targets Membrane Interacting Peptides: A Review
Current Protein & Peptide Science Targeted Delivery of Tumor Suppressor microRNA-1 by Transferrin- Conjugated Lipopolyplex Nanoparticles to Patient-Derived Glioblastoma Stem Cells
Current Pharmaceutical Biotechnology miR-149 as a Potential Molecular Target for Cancer
Current Medicinal Chemistry